Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Samkoff

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Neurology|November 30, 2016
Teaching NeuroImages: Idiopathic hypertrophic pachymeningitisAndrea Wasilewski, Lawrence Samkoff
Neurology|June 7, 2017
Author response: Teaching NeuroImages: Idiopathic hypertrophic pachymeningitisAndrea Wasilewski, Lawrence Samkoff
JAMA Neurology|November 10, 2015
Non-N-Methyl-D-Aspartate Receptor Antibody Encephalitis With Cerebellitis With Associated Ovarian TeratomaAndrew D Smith, Lawrence Samkoff
Neurology|May 25, 2005
Leukoencephalopathy from "chasing the dragon"Owen Halloran, Sarah Ifthikharuddin, Lawrence Samkoff
Current Treatment Options in Oncology|January 10, 2024
Management of Paraneoplastic Syndromes in the Era of Immune Checkpoint InhibitorsMaxime Junior Jean, Lawrence Samkoff, Nimish Mohile
JAAD Case Reports|August 17, 2021
Relapsing-remitting multiple sclerosis arising in a patient with atopic dermatitis on dupilumabLeah Laageide, Brendon Verhave, Lawrence Samkoff, et al.
Journal of Neuroimmunology|October 21, 2022
GFAP astrocytopathy presenting with profound intracranial hypertension and vision lossRyan Canissario, Lawrence Samkoff, Maxime Junior Jean, et al.
Neurology|May 11, 2016
Fingolimod-associated PML in a patient with prior immunosuppressionTirisham V Gyang, Johanna Hamel, Andrew D Goodman, et al.
Frontiers in Immunology|March 3, 2020
The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal AntibodiesDavid Baker, Liaqat Ali, Gauri Saxena, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 24, 2017
Safety/tolerability of the anti-semaphorin 4D Antibody VX15/2503 in a randomized phase 1 trialChristopher LaGanke, Lawrence Samkoff, Keith Edwards, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neurology|November 30, 2016
Teaching NeuroImages: Idiopathic hypertrophic pachymeningitisAndrea Wasilewski, Lawrence Samkoff
Neurology|June 7, 2017
Author response: Teaching NeuroImages: Idiopathic hypertrophic pachymeningitisAndrea Wasilewski, Lawrence Samkoff
JAMA Neurology|November 10, 2015
Non-N-Methyl-D-Aspartate Receptor Antibody Encephalitis With Cerebellitis With Associated Ovarian TeratomaAndrew D Smith, Lawrence Samkoff
Neurology|May 25, 2005
Leukoencephalopathy from "chasing the dragon"Owen Halloran, Sarah Ifthikharuddin, Lawrence Samkoff
Current Treatment Options in Oncology|January 10, 2024
Management of Paraneoplastic Syndromes in the Era of Immune Checkpoint InhibitorsMaxime Junior Jean, Lawrence Samkoff, Nimish Mohile
JAAD Case Reports|August 17, 2021
Relapsing-remitting multiple sclerosis arising in a patient with atopic dermatitis on dupilumabLeah Laageide, Brendon Verhave, Lawrence Samkoff, et al.
Journal of Neuroimmunology|October 21, 2022
GFAP astrocytopathy presenting with profound intracranial hypertension and vision lossRyan Canissario, Lawrence Samkoff, Maxime Junior Jean, et al.
Neurology|May 11, 2016
Fingolimod-associated PML in a patient with prior immunosuppressionTirisham V Gyang, Johanna Hamel, Andrew D Goodman, et al.
Frontiers in Immunology|March 3, 2020
The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal AntibodiesDavid Baker, Liaqat Ali, Gauri Saxena, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 24, 2017
Safety/tolerability of the anti-semaphorin 4D Antibody VX15/2503 in a randomized phase 1 trialChristopher LaGanke, Lawrence Samkoff, Keith Edwards, et al.
Pageof 1